Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Becker

Showing results (191-200 of 274) with videos related to

Pageof 28
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|December 5, 2024
Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administrationSree Kurup, Nieves Velez de Mendizabal, Stephan Becker, et al.
Journal of Virology|November 16, 2018
Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat CellsMarkus Hoffmann, Inga Nehlmeier, Constantin Brinkmann, et al.
Iscience|April 5, 2021
The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infectionGergely Imre, Verena Krähling, Madeleine Eichler, et al.
Lancet (London, England)|December 24, 2014
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive careTimo Wolf, Gerrit Kann, Stephan Becker, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2022
Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 InfectionLucie Sauerhering, Irina Kuznetsova, Alexandra Kupke, et al.
Virology|July 30, 2005
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirusThomas Gramberg, Heike Hofmann, Peggy Möller, et al.
The Journal of Infectious Diseases|April 16, 2013
Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)Ariel Sobarzo, Allison Groseth, Olga Dolnik, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2014
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entryGerrit Gehring, Katrin Rohrmann, Nkacheh Atenchong, et al.
Plos Neglected Tropical Diseases|May 2, 2017
External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West AfricaHeinz Ellerbrok, Sonja Jacobsen, Pranav Patel, et al.
Clinical Chemistry and Laboratory Medicine|August 2, 2012
Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogensThomas Strecker, Jennifer Uhlendorff, Sandra Diederich, et al.
Pageof 28

Showing results (191-200 of 274) with videos related to

Sort By:
Pageof 28
Journal of Pharmacokinetics and Pharmacodynamics|December 5, 2024
Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administrationSree Kurup, Nieves Velez de Mendizabal, Stephan Becker, et al.
Journal of Virology|November 16, 2018
Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat CellsMarkus Hoffmann, Inga Nehlmeier, Constantin Brinkmann, et al.
Iscience|April 5, 2021
The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infectionGergely Imre, Verena Krähling, Madeleine Eichler, et al.
Lancet (London, England)|December 24, 2014
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive careTimo Wolf, Gerrit Kann, Stephan Becker, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2022
Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 InfectionLucie Sauerhering, Irina Kuznetsova, Alexandra Kupke, et al.
Virology|July 30, 2005
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirusThomas Gramberg, Heike Hofmann, Peggy Möller, et al.
The Journal of Infectious Diseases|April 16, 2013
Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)Ariel Sobarzo, Allison Groseth, Olga Dolnik, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2014
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entryGerrit Gehring, Katrin Rohrmann, Nkacheh Atenchong, et al.
Plos Neglected Tropical Diseases|May 2, 2017
External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West AfricaHeinz Ellerbrok, Sonja Jacobsen, Pranav Patel, et al.
Clinical Chemistry and Laboratory Medicine|August 2, 2012
Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogensThomas Strecker, Jennifer Uhlendorff, Sandra Diederich, et al.
Pageof 28